XML 35 R22.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Significant Accounting Policies - Additional Information (Detail) | 1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jan. 31, 2017 USD ($) | Jan. 31, 2012 | Mar. 31, 2017 USD ($) | Jun. 30, 2016 USD ($) | Jun. 30, 2017 USD ($) Segment | Jun. 30, 2016 USD ($) | Dec. 31, 2016 USD ($) | Jan. 20, 2017 USD ($) | Dec. 31, 2015 USD ($) | Nov. 30, 2015 USD ($) | May 31, 2014 USD ($) | Dec. 31, 2012 USD ($)
Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Sales discount percentage |  |  |  |  | 2.00% |  |  |  |  |  |  |
Trade receivables, credit period |  |  |  |  | 30 days |  |  |  |  |  |  |
Accounts receivable written off |  |  |  |  | $ 0 |  |  |  |  |  |  |
Gain (loss) on change in fair value of derivative liabilities |  |  |  | $ 5,810,000 |  | $ 4,560,000 |  |  |  |  |  |
Number of operating segments | Segment |  |  |  |  | 1 |  |  |  |  |  |  |
Embedded Derivative Financial Instruments | BioPharma Debt |  |  |  |  |  |  |  |  |  |  |  |
Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Maximum repayment of future revenue and receivables |  |  |  |  |  |  |  |  |  |  |  | $ 150,000,000
Fair value of embedded derivative liability |  |  |  | 2,800,000 | $ 0 | 2,800,000 | $ 0 |  | $ 5,500,000 |  |  |
Gain (loss) on change in fair value of derivative liabilities |  |  |  |  | $ 0 | $ 2,700,000 |  |  |  |  |  |
Embedded Derivative Financial Instruments | BioPharma Debt | Minimum |  |  |  |  |  |  |  |  |  |  |  |
Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Derivative liability fair value assumptions, term |  |  |  |  | 1 year 10 months 25 days |  | 2 years 4 months 24 days |  |  |  |  |
Derivative liability fair value assumption, coupon rate |  |  |  |  | 8.10% |  | 8.10% |  |  |  |  |
Derivative liability fair value assumptions, market yields |  |  |  |  | 8.10% |  | 11.90% |  |  |  |  |
Embedded Derivative Financial Instruments | BioPharma Debt | Maximum |  |  |  |  |  |  |  |  |  |  |  |
Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Derivative liability fair value assumptions, term |  |  |  |  | 4 years 6 months |  | 5 years |  |  |  |  |
Derivative liability fair value assumption, coupon rate |  |  |  |  | 11.10% |  | 11.10% |  |  |  |  |
Derivative liability fair value assumptions, market yields |  |  |  |  | 17.50% |  | 18.40% |  |  |  |  |
Top Three Customers | Gross Product Sales | Customer Concentration Risk |  |  |  |  |  |  |  |  |  |  |  |
Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Concentration risk percentage |  |  |  |  | 92.00% | 95.00% |  |  |  |  |  |
Top Three Customers | Accounts Receivable | Customer Concentration Risk |  |  |  |  |  |  |  |  |  |  |  |
Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Concentration risk percentage |  |  |  |  | 86.00% | 94.00% |  |  |  |  |  |
2012 Notes |  |  |  |  |  |  |  |  |  |  |  |
Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Aggregate principal amount of notes | $ 15,000,000 |  |  |  |  |  |  |  |  |  |  |
Aggregate principal amount redeemed | 100,000 |  |  |  |  |  |  |  |  |  |  |
2017 Notes |  |  |  |  |  |  |  |  |  |  |  |
Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Aggregate principal amount of notes |  |  |  |  | $ 30,000,000 |  |  |  |  |  |  |
Convertible senior notes, discount |  |  |  |  | $ 1,200,000 |  |  |  |  |  |  |
Convertible Debt | 2012 Notes |  |  |  |  |  |  |  |  |  |  |  |
Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Aggregate principal amount of notes |  |  |  |  |  |  | $ 15,107,000 |  |  |  |  |
Convertible senior notes, discount |  |  |  |  |  |  | $ 0 |  |  |  |  |
Note, expected term |  | 24 months |  |  | 24 months |  |  |  |  |  |  |
Convertible senior notes, principal amount purchase | $ 15,000,000 |  | $ 15,000,000 |  |  |  |  |  |  | $ 16,200,000 |  |
Convertible senior notes, aggregate principal amount redeemed |  |  | $ 100,000 |  | $ 100,000 |  |  |  |  |  |  |
Convertible senior notes, outstanding amount |  |  |  |  | 0 |  |  |  |  |  |  |
Convertible Debt | 2017 Notes |  |  |  |  |  |  |  |  |  |  |  |
Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Convertible senior notes, discount |  |  |  |  | 1,100,000 |  |  | $ 1,200,000 |  |  |  |
Convertible Debt | 2014 Notes |  |  |  |  |  |  |  |  |  |  |  |
Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Convertible senior notes, discount |  |  |  |  |  |  |  |  |  |  | $ 27,900,000 |
Fair value of embedded derivative liability |  |  |  | 600,000 |  | $ 600,000 |  |  | 2,100,000 |  |  |
Gain (loss) on change in fair value of derivative liabilities |  |  |  |  |  | 1,500,000 |  |  |  |  |  |
Convertible Debt | 2014 Notes and 2015 Notes |  |  |  |  |  |  |  |  |  |  |  |
Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Gain (loss) on change in fair value of derivative liabilities |  |  |  |  | $ 0 |  |  |  |  |  |  |
Convertible Debt | 2015 Notes |  |  |  |  |  |  |  |  |  |  |  |
Significant Accounting Policies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Convertible senior notes, discount |  |  |  |  |  |  |  |  |  | $ 3,800,000 |  |
Fair value of embedded derivative liability |  |  |  | $ 200,000 |  | 200,000 |  |  | $ 600,000 |  |  |
Gain (loss) on change in fair value of derivative liabilities |  |  |  |  |  | $ 400,000 |  |  |  |  |  |

X
- Definition Accounts receivable credit period + References No definition available. + Details
Name: | amrn_AccountsReceivableCreditPeriod
Namespace Prefix: | amrn_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cash discount percent. + References No definition available. + Details
Name: | amrn_CashDiscountPercent
Namespace Prefix: | amrn_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Debt instrument aggregate principal amount redeemed. + References No definition available. + Details
Name: | amrn_DebtInstrumentAggregatePrincipalAmountRedeemed
Namespace Prefix: | amrn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Fair value assumptions, comparable yield to maturity. + References No definition available. + Details
Name: | amrn_FairValueAssumptionsComparableYieldToMaturity
Namespace Prefix: | amrn_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value assumptions coupon rate. + References No definition available. + Details
Name: | amrn_FairValueAssumptionsCouponRate
Namespace Prefix: | amrn_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Significant accounting policies. + References No definition available. + Details
Name: | amrn_SignificantAccountingPoliciesLineItems
Namespace Prefix: | amrn_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Write offs of accounts receivables. + References No definition available. + Details
Name: | amrn_WriteOffsOfAccountsReceivables
Namespace Prefix: | amrn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6351-108592 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13531-108611 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6404-108592 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13537-108611 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(19)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_ConvertibleDebtCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Face (par) amount of the original debt instrument that was repurchased. + References No definition available. + Details
Name: | us-gaap_DebtInstrumentRepurchasedFaceAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | us-gaap_DebtInstrumentTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, after accumulated amortization, of debt discount. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 55 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400 + Details
Name: | us-gaap_DebtInstrumentUnamortizedDiscount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=84234895&loc=SL5624163-113959 + Details
Name: | us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssumptionsExpectedTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. + References No definition available. + Details
Name: | us-gaap_NumberOfOperatingSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions. + References No definition available. + Details
Name: | us-gaap_OtherCommitment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations. + References No definition available. + Details
Name: | us-gaap_RepaymentsOfDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.16(a)) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.16) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 + Details
Name: | us-gaap_SeniorNotes
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585 + Details
Name: | us-gaap_UnrealizedGainLossOnDerivatives
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=amrn_BiopharmaceuticalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MajorCustomersAxis=amrn_TopThreeCustomerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongtermDebtTypeAxis=amrn_SeniorNotesOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongtermDebtTypeAxis=amrn_SeniorNotesFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=amrn_SeniorNotesOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=amrn_SeniorNotesFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=amrn_SeniorNotesTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=amrn_SeniorNotesTwoAndThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=amrn_SeniorNotesThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |